Home / Creating a SOX Compliance Program for a Newly Public Pharma Company
A newly public, pre-revenue biopharmaceutical company engaged SolomonEdwards to develop its Year 1 program for compliance with Sarbanes-Oxley 404. The client wanted to ensure it had a stringent compliance program capable of ongoing annual assessments and external auditor reliance.
Drawing upon industry acumen and best practices, we provided a comprehensive SOX compliance program to both improve operational efficiency and meet regulatory standards, thereby securing a strategic advantage for the firm during the pivotal early stages of public investment. Key elements of the program included:
SolomonEdwards’ development of the company’s SOX compliance program enabled strict adherence to regulatory standards while also enhancing operations. The compliance program has given the company a solid foundation for ongoing compliance and for external audit reliance on management testing. These efforts also enabled the company to successfully complete the Year 1 SOX 404 assessment, develop an efficient and robust SOX compliance program, and identify recommendations for future optimization efforts.